Skip to content

A clinical study of explore wearable applicability of low-power irradiator for knee joint pain

A clinical study of explore wearable applicability of low-power irradiator for knee joint pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009377
Enrollment
12
Registered
2024-04-26
Start date
2024-04-03
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : 6 people to the control group (a group in which a low-power irradiator was applied for 15 minutes) after the test group (a group in which a low-power irradiator was applied for 120 mi

Sponsors

Cheonan Korean Medicine Hospital of Daejeon University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged between 19 and 64 years old 2. Those who agree to participate in this study and voluntarily sign this study 3. Those whose VAS(visual analog scale) of knee joint pain is 40 or higher

Exclusion criteria

Exclusion criteria: 1. Those who have skin allergies or abnormal reactions to sunlight 2. Those with other chronic diseases (stroke, myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.) that may interfere with the treatment effect or interpretation of results. 3. Those who have a skin wound on the affected knee and are at risk of infection 4. Patients with malignant tumors (can participate if no recurrence occurs within 5 years after completion of treatment) 5. Those currently taking steroids (prednisolone, methylprednisolone, betamethasone, dexamethasone, hydrocortisone, etc.), immunosuppressants (calcineurin inhibitors (cycloproline, tacrolimus), mTOR inhibitors (sharolimus, everolimus), antimetabolites (mycophenolate), drugs for mental illness (antidepressants (lorazepam, alprazolam, sertraline), anti-anxiety drugs (benzodiazepines, buspirone), etc.) or other drugs that may affect the results of the study. 6. Those who have participated in clinical trials for the treatment of knee joint pain within the past 3 months 7. Pregnant or breastfeeding 8. Those who participated in another clinical study and received intervention within 4 weeks of the screening visit of this study 9. Those who have difficulty filling out the consent form to participate in research 10. Other people who, in the opinion of the researcher, find it difficult to participate in clinical research 11. Those who have had knee surgery within 3 months

Design outcomes

Primary

MeasureTime frame
Knee joint pain VAS(Visual Analogue Scale)

Secondary

MeasureTime frame
Western Ontario and McMaster Universities Index;EuroQoL 5-Dimension 5-Level;Convenience evaluation

Countries

Korea, Republic of

Contacts

Public ContactJae-hui Kang

Cheonan Korean Medicine Hospital of Daejeon University

rkd12@hanmail.net+82-41-521-7579

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026